OCULAR THERAPEUTIX, INC - OCUL
Insiders (Form 4) · last 180 days · showing up to 200 transactions
· Form 144 is shown in the SEC filings tab
· Updating…
Visible: 0
Transaction codes:
P = Open-market purchase ·
S = Open-market sale ·
A = Grant/award ·
M = Exercise/conversion of derivative ·
G = Gift ·
F = Tax withholding ·
J = Other ·
A/D:
A = Acquired (buy/receive) ·
D = Disposed (sell/give)
| Filed | Owner | Title | Code | A/D | Shares | Price | Value | Shares after | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Sep 02, 2026 | Chief Operating Officer | S | D | 1,099.0 | 10.24 | 11,253.76 | 366,529.0 | View | |
| Aug 26, 2026 | Chief Development Officer | S | D | 3,035.0 | 10.77 | 32,686.95 | 264,378.0 | View | |
| Aug 26, 2026 | Chief Strategy Officer | S | D | 1,897.0 | 10.78 | 20,449.66 | 326,898.0 | View | |
| Aug 26, 2026 | Chief Scientific Officer | S | D | 3,296.0 | 10.78 | 35,530.88 | 318,326.0 | View | |
| Aug 26, 2026 | See Remarks | G | A | 50,092.0 | 0.0 | 0.0 | 744,903.0 | View | |
| Aug 26, 2026 | See Remarks | G | D | 50,092.0 | 0.0 | 0.0 | 0.0 | View | |
| Aug 26, 2026 | See Remarks | S | D | 21,649.0 | 10.77 | 233,159.73 | 2,525,429.0 | View | |
| Jun 18, 2026 | See Remarks | G | A | 50,092.0 | 0.0 | 0.0 | 50,092.0 | View | |
| Jun 18, 2026 | See Remarks | G | D | 50,092.0 | 0.0 | 0.0 | 2,547,078.0 | View | |
| Jun 12, 2026 | — | A | A | 44,000.0 | 0.0 | 0.0 | 44,000.0 | View | |
| Jun 12, 2026 | — | A | A | 14,000.0 | 0.0 | 0.0 | 100,464.0 | View | |
| Jun 12, 2026 | — | A | A | 44,000.0 | 0.0 | 0.0 | 44,000.0 | View | |
| Jun 12, 2026 | — | A | A | 14,000.0 | 0.0 | 0.0 | 64,000.0 | View | |
| Jun 12, 2026 | Chief Financial Officer | A | A | 14,024.0 | 0.0 | 0.0 | 14,024.0 | View | |
| Jun 12, 2026 | Chief Financial Officer | A | A | 15,441.0 | 0.0 | 0.0 | 68,097.0 | View | |
| Jun 12, 2026 | — | A | A | 44,000.0 | 0.0 | 0.0 | 44,000.0 | View | |
| Jun 12, 2026 | — | A | A | 14,000.0 | 0.0 | 0.0 | 60,933.0 | View | |
| Jun 12, 2026 | — | A | A | 44,000.0 | 0.0 | 0.0 | 44,000.0 | View | |
| Jun 12, 2026 | — | A | A | 14,000.0 | 0.0 | 0.0 | 260,933.0 | View | |
| Jun 12, 2026 | — | A | A | 44,000.0 | 0.0 | 0.0 | 44,000.0 | View | |
| Jun 12, 2026 | — | A | A | 14,000.0 | 0.0 | 0.0 | 60,933.0 | View | |
| Jun 12, 2026 | — | A | A | 44,000.0 | 0.0 | 0.0 | 44,000.0 | View | |
| Jun 12, 2026 | — | A | A | 14,000.0 | 0.0 | 0.0 | 65,433.0 | View | |
| Jun 05, 2026 | Chief Medical Officer | S | D | 14,828.0 | 8.27 | 122,627.56 | 300,079.0 | View | |
| May 28, 2026 | See Remarks | G | A | 394,696.0 | 0.0 | 0.0 | 694,811.0 | View | |
| May 28, 2026 | See Remarks | G | D | 394,696.0 | 0.0 | 0.0 | 0.0 | View | |
| May 28, 2026 | See Remarks | S | D | 21,156.0 | 8.2 | 173,479.2 | 2,597,170.0 | View | |
| May 28, 2026 | Chief Development Officer | S | D | 2,967.0 | 8.2 | 24,329.4 | 266,141.0 | View | |
| May 28, 2026 | Chief Scientific Officer | S | D | 3,018.0 | 8.2 | 24,747.6 | 320,350.0 | View | |
| May 28, 2026 | Chief Strategy Officer | S | D | 1,858.0 | 8.2 | 15,235.6 | 328,795.0 | View | |
| Apr 13, 2026 | See Remarks | G | A | 394,696.0 | 0.0 | 0.0 | 394,696.0 | View | |
| Apr 13, 2026 | See Remarks | G | D | 394,696.0 | 0.0 | 0.0 | 2,618,326.0 | View |